Muneer Satter manages Satter Investment Management, a private investment firm focused on medical technology investments. He was chairman of Akebia Therapeutics, a publicly traded biotech company focused on the treatment of anemia. He is chairman of Aerpio Therapeutics, a biotech company for the treatment of diabetic macular edema. He is a director of Annexon which is a complement cascade pathway company focused on autoimmune and neurologic diseases. He is chairman of Restorsea, a company which holds exclusive rights to a unique enzyme for an anti-aging cream. Mr. Satter is vice chairman of the board of the Goldman Sachs Foundation and Goldman Sachs Gives. He also serves as chairman of the finance committee on the board of Northwestern University. He is also a member of the Board of the Navy SEAL Foundation. He is a member of the Board of the Northwestern Medical Group (over 1,000 doctors and over $1 billion of revenue). He is on the Board of Advisors of Accelerate Institute (which provides leadership training for school principals). Additionally, he is on the Board of Advisors of the American Enterprise Institute and the Board of World Business Chicago (chaired by Mayor Rahm Emanuel). He is a member of the Council on Foreign Relations. He is a former co-chairman of Room to Read (which builds 2,000 libraries and schools per year in developing countries). He is a former member of the Board of the Nature Conservancy where he was chairman of the Finance Committee overseeing a $1.8 billion endowment.
Mr. Satter is a retired partner at Goldman Sachs, where he was a partner of the firm for 16 years, in the Merchant Banking Division which manages the firm’s private investments. Mr. Satter received a B.A. from Northwestern University, and a JD/MBA from Harvard Law School and Harvard Business School. He lives in Chicago, IL with his wife, Kristen, and their five daughters.